107 related articles for article (PubMed ID: 27860405)
21. Staphylococcal display for combinatorial protein engineering of a head-to-tail affibody dimer binding the Alzheimer amyloid-β peptide.
Lindberg H; Johansson A; Härd T; Ståhl S; Löfblom J
Biotechnol J; 2013 Jan; 8(1):139-45. PubMed ID: 22987778
[TBL] [Abstract][Full Text] [Related]
22. Kinesin-1 inhibits the aggregation of amyloid-β peptide as detected by fluorescence cross-correlation spectroscopy.
Zheng Y; Tian S; Peng X; Yang J; Fu Y; Jiao Y; Zhao J; He J; Hong T
FEBS Lett; 2016 Apr; 590(7):1028-37. PubMed ID: 26991731
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the effects of amyloid β aggregation from seaweed extracts by a microliter-scale high-throughput screening system with a quantum dot nanoprobe.
Ogara T; Takahashi T; Yasui H; Uwai K; Tokuraku K
J Biosci Bioeng; 2015 Jul; 120(1):45-50. PubMed ID: 25534595
[TBL] [Abstract][Full Text] [Related]
24. Black tea theaflavins inhibit formation of toxic amyloid-β and α-synuclein fibrils.
Grelle G; Otto A; Lorenz M; Frank RF; Wanker EE; Bieschke J
Biochemistry; 2011 Dec; 50(49):10624-36. PubMed ID: 22054421
[TBL] [Abstract][Full Text] [Related]
25. A strategy for designing inhibitors of alpha-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders.
El-Agnaf OM; Paleologou KE; Greer B; Abogrein AM; King JE; Salem SA; Fullwood NJ; Benson FE; Hewitt R; Ford KJ; Martin FL; Harriott P; Cookson MR; Allsop D
FASEB J; 2004 Aug; 18(11):1315-7. PubMed ID: 15180968
[TBL] [Abstract][Full Text] [Related]
26. Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.
Liu D; Xu Y; Feng Y; Liu H; Shen X; Chen K; Ma J; Jiang H
Biochemistry; 2006 Sep; 45(36):10963-72. PubMed ID: 16953582
[TBL] [Abstract][Full Text] [Related]
27. De novo design of self-assembled hexapeptides as β-amyloid (Aβ) peptide inhibitors.
Wang Q; Liang G; Zhang M; Zhao J; Patel K; Yu X; Zhao C; Ding B; Zhang G; Zhou F; Zheng J
ACS Chem Neurosci; 2014 Oct; 5(10):972-81. PubMed ID: 25133634
[TBL] [Abstract][Full Text] [Related]
28. Testing synthetic amyloid-β aggregation inhibitor using single molecule atomic force spectroscopy.
Hane FT; Lee BY; Petoyan A; Rauk A; Leonenko Z
Biosens Bioelectron; 2014 Apr; 54():492-8. PubMed ID: 24321883
[TBL] [Abstract][Full Text] [Related]
29. Yeast as a Model for Studies on Aβ Aggregation Toxicity in Alzheimer's Disease, Autophagic Responses, and Drug Screening.
Porzoor A; Macreadie I
Methods Mol Biol; 2016; 1303():217-26. PubMed ID: 26235069
[TBL] [Abstract][Full Text] [Related]
30. Fluorescence imaging of amyloid formation in living cells by a functional, tetracysteine-tagged alpha-synuclein.
Roberti MJ; Bertoncini CW; Klement R; Jares-Erijman EA; Jovin TM
Nat Methods; 2007 Apr; 4(4):345-51. PubMed ID: 17351621
[TBL] [Abstract][Full Text] [Related]
31. A bacteriophage capsid protein provides a general amyloid interaction motif (GAIM) that binds and remodels misfolded protein assemblies.
Krishnan R; Tsubery H; Proschitsky MY; Asp E; Lulu M; Gilead S; Gartner M; Waltho JP; Davis PJ; Hounslow AM; Kirschner DA; Inouye H; Myszka DG; Wright J; Solomon B; Fisher RA
J Mol Biol; 2014 Jun; 426(13):2500-19. PubMed ID: 24768993
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of ferrocenoyl pentapeptide (Fc-KLVFF) as an inhibitor of Alzheimer's Aβ₁-₄₂ fibril formation in vitro.
Wei CW; Peng Y; Zhang L; Huang Q; Cheng M; Liu YN; Li J
Bioorg Med Chem Lett; 2011 Oct; 21(19):5818-21. PubMed ID: 21855336
[TBL] [Abstract][Full Text] [Related]
33. A β-hairpin-binding protein for three different disease-related amyloidogenic proteins.
Shaykhalishahi H; Mirecka EA; Gauhar A; Grüning CS; Willbold D; Härd T; Stoldt M; Hoyer W
Chembiochem; 2015 Feb; 16(3):411-4. PubMed ID: 25557164
[TBL] [Abstract][Full Text] [Related]
34. Influence of the β-sheet content on the mechanical properties of aggregates during amyloid fibrillization.
Ruggeri FS; Adamcik J; Jeong JS; Lashuel HA; Mezzenga R; Dietler G
Angew Chem Int Ed Engl; 2015 Feb; 54(8):2462-6. PubMed ID: 25588987
[TBL] [Abstract][Full Text] [Related]
35. A Ligand-Based NMR Screening Approach for the Identification and Characterization of Inhibitors and Promoters of Amyloid Peptide Aggregation.
Dalvit C; Santi S; Neier R
ChemMedChem; 2017 Sep; 12(17):1458-1463. PubMed ID: 28722296
[TBL] [Abstract][Full Text] [Related]
36. Large-scale production of soluble recombinant amyloid-β peptide 1-42 using cold-inducible expression system.
Kim EK; Moon JC; Lee JM; Jeong MS; Oh C; Ahn SM; Yoo YJ; Jang HH
Protein Expr Purif; 2012 Nov; 86(1):53-7. PubMed ID: 22982229
[TBL] [Abstract][Full Text] [Related]
37. A Fluorescence-Based Sensor Assay that Monitors General Protein Aggregation in Human Cells.
Pereira M; Tomé D; Domingues AS; Varanda AS; Paulo C; Santos MAS; Soares AR
Biotechnol J; 2018 Apr; 13(4):e1700676. PubMed ID: 29345424
[TBL] [Abstract][Full Text] [Related]
38. Hemin as a generic and potent protein misfolding inhibitor.
Liu Y; Carver JA; Ho LH; Elias AK; Musgrave IF; Pukala TL
Biochem Biophys Res Commun; 2014 Nov; 454(2):295-300. PubMed ID: 25450392
[TBL] [Abstract][Full Text] [Related]
39. Green fluorescent protein (GFP)-dependent separation of bacterial ghosts from intact cells by FACS.
Haidinger W; Szostak MP; Beisker W; Lubitz W
Cytometry; 2001 Jun; 44(2):106-12. PubMed ID: 11378860
[TBL] [Abstract][Full Text] [Related]
40. Combinatorial expression vector engineering for tuning of recombinant protein production in Escherichia coli.
Bandmann N; Nygren PA
Nucleic Acids Res; 2007; 35(5):e32. PubMed ID: 17264122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
